Manning & Napier Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Manning & Napier Advisors's PFE Position: Q1 2026 in Review
Manning & Napier Advisors increased its Pfizer (PFE) stake by 58% in Q1 2026, buying an estimated $761K and bringing the position to 77,663 shares worth $2.18M. The position accounts for 0.03% of the portfolio, ranked #227.
Manning & Napier Advisors first reported a position in PFE in Q2 2013 and has held it in 20 quarters since. The position peaked at $32.1M in Q3 2013. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Manning & Napier Advisors held 77,663 shares of Pfizer worth $2.18M as of Q1 2026.
- Manning & Napier Advisors bought 28,590 Pfizer shares in Q1 2026, an estimated $761K.
- Pfizer made up 0.03% of Manning & Napier Advisors's portfolio in Q1 2026, its #227 holding.
- Manning & Napier Advisors first reported a position in Pfizer in Q2 2013 and has held it in 20 quarters since.
- Manning & Napier Advisors's Pfizer position peaked at $32.1M in Q3 2013.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Manning & Napier Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.